Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness
Glioblastoma is the most commonly malignant and aggressive brain tumor, with a high mortality rate. The role of the purine nucleotide adenosine and its interaction with its four subtypes receptors coupled to the different G proteins, A1, A2A, A2B, and A3, and its different physiological functions in...
Main Authors: | Valentina Bova, Alessia Filippone, Giovanna Casili, Marika Lanza, Michela Campolo, Anna Paola Capra, Alberto Repici, Lelio Crupi, Gianmarco Motta, Cristina Colarossi, Giulia Chisari, Salvatore Cuzzocrea, Emanuela Esposito, Irene Paterniti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/16/4032 |
Similar Items
-
Adenosine, Adenosine Receptors and Neurohumoral Syncope: From Molecular Basis to Personalized Treatment
by: Régis Guieu, et al.
Published: (2022-05-01) -
Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches
by: Luiza R. Nazario, et al.
Published: (2017-11-01) -
Blocking Adenosine/A2AR Pathway for Cancer Therapy
by: Jia LIU, et al.
Published: (2022-07-01) -
Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases
by: Wiwin Is Effendi, et al.
Published: (2020-03-01) -
Adenosine and Adenosine Receptors: Advances in Atrial Fibrillation
by: Baptiste Maille, et al.
Published: (2022-11-01)